ArticlePharmacoEconomics2023
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy.
Carla Rognoni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it